LTGHF OTC
Life Healthcare Group Holdings Limited
1W: +0.0%
1M: +0.0%
3M: -15.3%
YTD: -12.4%
1Y: -12.4%
3Y: +41.4%
5Y: +58.0%
$0.69
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$232M
-93.8% ▼
5Y CAGR: -43.5%
Capital Expenditures
$94M
+93.9% ▲
5Y CAGR: -45.5%
Free Cash Flow
$138M
-93.6% ▼
5Y CAGR: -41.8%
Dividends Paid
$301M
+96.8% ▲
Buybacks
$23M
+91.8% ▲
Net Change in Cash
$77M
-95.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.6B | $2.5B | $66M | $2.7B | -$620M |
| Depreciation & Amort. | $2.1B | $2.2B | $59M | $1.3B | $1.3B |
| Stock-Based Comp. | $96M | $184M | $0 | $298M | $352M |
| Change in Working Capital | $381M | -$52M | -$15M | -$385M | $24M |
| Other Non-Cash Items | $724M | -$595M | $4.6B | -$191M | -$835M |
| Operating Cash Flow | $5.1B | $4.2B | $4.7B | $3.7B | $232M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.9B | -$2.3B | -$80M | -$1.3B | -$1.6B |
| Acquisitions (Net) | $401M | -$388M | -$3M | $19.0B | $5.6B |
| Investment Purchases | -$5M | $0 | -$158K | -$121M | $0 |
| Investment Sales | $5M | $0 | $0 | $0 | $0 |
| Other Investing | $28M | $33M | -$2.8B | -$922M | -$3.8B |
| Investing Cash Flow | -$1.5B | -$2.7B | -$2.9B | $16.7B | $223M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$347M | $758M | -$6M | -$8.8B | $0 |
| Stock Repurchased | -$31M | -$302M | -$121M | -$285M | -$23M |
| Dividends Paid | $0 | -$587M | -$32M | -$9.5B | -$301M |
| Other Financing | -$877M | -$776M | -$2.6B | -$1.1B | -$50M |
| Financing Cash Flow | -$1.3B | -$1.4B | -$2.6B | -$19.6B | -$374M |
| Net Change in Cash | $2.2B | $120M | -$1.8B | $1.8B | $77M |
| Cash End of Period | $2.3B | $2.5B | $659M | $2.5B | $219M |
| Free Cash Flow | $3.2B | $1.9B | $149M | $2.2B | $138M |